SUMOylation of the kainate receptor subunit GluK2 contributes to the activation of the MLK3-JNK3 pathway following kainate stimulation

FEBS Lett. 2012 May 7;586(9):1259-64. doi: 10.1016/j.febslet.2012.03.048. Epub 2012 Mar 31.

Abstract

Protein SUMOylation has been implicated in the pathogenesis of ischemic stroke. However, the underlying mechanisms remain unclear. Here, we found that global brain ischemia evokes a sustained elevation of GluK2 SUMOylation in the rat hippocampal CA1 region. Over-expression of wild-type GluK2, but not SUMOylation-deficient mutant, significantly increased the activity of MLK3 and JNK3 after kainate stimulation. SUMOylation deficiency attenuated the kainate-stimulated interaction between MLK3 and GluK2. In addition, inhibition of kainate-evoked GluK2 endocytosis decreased the activation of MLK3-JNK3 signaling and the binding of MLK3-GluK2 in cultured cortical neurons. These results suggest that the internalization of GluK2 following SUMO modification promotes its binding with MLK3, thereby activating the MLK3-JNK3 pathway, which may be responsible for ischemic neuronal cell death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • CA1 Region, Hippocampal / metabolism
  • CA1 Region, Hippocampal / pathology
  • COS Cells
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Enzyme Activation / drug effects
  • GluK2 Kainate Receptor
  • Humans
  • Kainic Acid / pharmacology*
  • MAP Kinase Kinase Kinases / metabolism*
  • MAP Kinase Signaling System / drug effects*
  • Male
  • Mitogen-Activated Protein Kinase 10 / metabolism*
  • Mitogen-Activated Protein Kinase Kinase Kinase 11
  • Phosphorylation / drug effects
  • Protein Transport / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Kainic Acid / metabolism*
  • Sumoylation / drug effects*

Substances

  • Receptors, Kainic Acid
  • Mitogen-Activated Protein Kinase 10
  • MAP Kinase Kinase Kinases
  • Kainic Acid